Search

everythinglearnresearchcommunity

for

Search:↓

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hormones significantly affect hair and oil gland function in the skin, and more research is needed on skin-related hormone disorders.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Excessive androgens in women with polycystic ovary syndrome can lead to excessive hair growth and hair loss, but this might not fully explain these conditions.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Flutamide is more effective and has fewer side effects than spironolactone for treating hirsutism.

Microparticles containing artocarpin extract could effectively treat hair loss and acne with minimal side effects.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

DHT, a testosterone byproduct, causes male pattern baldness.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Adiponectin reduces inflammation and bone loss in joint replacements.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.